EP2726088
PREDICTIVE BIOMARKER OF SURVIVAL IN THE TREATMENT OF RENAL CELL CARCINOMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.6.2012EP published:
2.1.2019EP application number:
12737394.2
EPO information:
European Patent Register
Max expiry date:
27.6.2032
Title:
PREDICTIVE BIOMARKER OF SURVIVAL IN THE TREATMENT OF RENAL CELL CARCINOMA
Timeline
Today
28.6.2012EP application
2.1.2019EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
Inventor
Name:
ANDERSON, Abraham, AntonioAddress:
Sherman Oaks, California, US
Name:
WEINREICH, David, M.Address:
Basking Ridge, New Jersey, US
Priority
Number:
201161502686 PDate:
29.6.2011Country:
US
Classification
Categories:
A61K 38/00, A61K 31/17, A61K 31/435, A61K 39/00, G01N 33/50, G01N 33/574, A61K 38/18, A61K 31/44, A61K 39/395, A61K 38/02